ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
262K |
15 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
262K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
2 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
22K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
262K |
9 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
262K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
262K |
16 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
262K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
adreamer
|
58 |
17K |
18 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
58
|
17K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
262K |
14 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
262K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
262K |
27 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
262K
|
27
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
262K |
9 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
978
|
262K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
adreamer
|
42 |
9.8K |
8 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
42
|
9.8K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
373K |
9 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
373K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
373K |
6 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
373K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
adreamer
|
42 |
9.8K |
25 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
42
|
9.8K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
adreamer
|
42 |
9.8K |
8 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
42
|
9.8K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
373K |
10 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
373K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
373K |
20 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.4K
|
373K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
adreamer
|
42 |
9.8K |
24 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
42
|
9.8K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
adreamer
|
86 |
22K |
30 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
86
|
22K
|
30
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
373K |
21 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.4K
|
373K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
19 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
250
|
66K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
13 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
250
|
66K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
14 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
250
|
66K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
38 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
250
|
66K
|
38
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
26 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
66K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
30 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
66K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Initial Director's Interest Notice x 2
|
|
adreamer
|
8 |
2.7K |
8 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
8
|
2.7K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Initial Director's Interest Notice x 2
|
|
adreamer
|
8 |
2.7K |
10 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
8
|
2.7K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
16 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
239
|
66K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Initial Director's Interest Notice x 2
|
|
adreamer
|
8 |
2.7K |
25 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
8
|
2.7K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
adreamer
|
83 |
24K |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
83
|
24K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
16 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
239
|
66K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
17 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
66K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
18 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
239
|
66K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
20 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
66K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
15 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
66K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
25 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
66K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
5 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
17 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
9 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
23 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
7 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
13 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
35 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
35
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
adreamer
|
250 |
66K |
37 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
66K
|
37
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
7 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
66K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
39 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
239
|
66K
|
39
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
24 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
239
|
66K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
34 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
239
|
66K
|
34
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
33 |
10K |
15 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
33
|
10K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
33 |
10K |
4 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
33
|
10K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
239 |
66K |
49 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
239
|
66K
|
49
|
|